The Künkele Lab

This is who we are.

You are here:

Third party funding

Integration in consortia

Berlin Institute of Health (BIH)

German Cancer Aid (Deutsche Krebshilfe)

  • ENABLE: Enabling MYC family protein druggability, fundig: since 2018
Berlin Institute of Health (BIH)

Project funding

Else Kröner Fresenius Stiftung

  • A CAR- T cell approch for solid tumor attack using neuroblastoma as a model (CASTAN), funding since 2018
Else Kröner Fresenius Stiftung

Children's Eye Cancer Foundation Germany KAKS

  • Evaluation of CAR-T cell therapy for retinoblastoma, since 2017
Children’s Eye Cancer Foundation Germany

German Cancer Consortium

  • Developing an off-the-shelf cell product for tumor-specific enhancement of inflammation and checkpoint inhibitor responsiveness; in cooperation with PD Dr. Sebastian Ochsenreither, since 2018
DKTK - German Cancer Consortium

Personal funding and stipends

Clinical Research Grant for Dr. Künkele

  • since 2015
Berlin Institute of Health (BIH)

Scholar Award of the William Guy Forbeck Research Foundation for Dr. Künkele

  • since 2015 - 2019
THE WILLIAM GUY FORBECK RESEARCH FOUNDATION

Junior Clinician Scientist Grant for Dr. Zirngibl

  • since 2017 - 2020
Berlin Institute of Health (BIH)

BSIO Fellowship for Laura Grunewald

  • since 2016
Berlin School of Integrative Oncology BSIO

MD Fellowship for Karin Töws from the BIH

  • since 2017
Berlin Institute of Health (BIH)

MD Fellowship for Ornela Sulejmani from the BIH

  • since 2019
Berlin Institute of Health (BIH)

MD Fellowship for Sara Marie Ivasko from the BIH

  • since 2019
Berlin Institute of Health (BIH)

Poster prize for Camilo Faust Akl, Bachelor Colloquium TU Berlin

  • January 2019

The copyright of the logos lies with the respective institution.